CLINICAL_TRIALS
trial_result
· 2026-02-19
Clinical Trial Update: CD160 Expression in Corneal Vessels
Summary
A completed clinical trial investigating CD160 expression in corneal vessels in the context of corneal graft rejection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: CHU de Reims | Conditions: Corneal Graft Rejection, CD160 | Status: COMPLETED